503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-24.85%
Both yoy net incomes decline, with BB at -274.51%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
10.56%
Some D&A expansion while BB is negative at -0.61%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
242.11%
Some yoy growth while BB is negative at -22.58%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
2.13%
SBC growth of 2.13% while BB is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
51.99%
Slight usage while BB is negative at -137.84%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
173.38%
AR growth while BB is negative at -112.14%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-78.17%
Negative yoy inventory while BB is 77.78%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-134.96%
Negative yoy AP while BB is 15.22%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
11.79%
Some yoy usage while BB is negative at -15.15%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-2.07%
Negative yoy while BB is 103.03%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
85.19%
Some CFO growth while BB is negative at -88.18%. John Neff would note a short-term liquidity lead over the competitor.
-14.03%
Negative yoy CapEx while BB is 46.67%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-46.72%
Both yoy lines negative, with BB at -3280.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
21.32%
Purchases well above BB's 7.09%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-26.09%
We reduce yoy sales while BB is 1.77%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-123.16%
We reduce yoy other investing while BB is 75.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-64.75%
Both yoy lines negative, with BB at -253.24%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-643.80%
We cut debt repayment yoy while BB is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
35.90%
Issuance growth of 35.90% while BB is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-4.87%
We cut yoy buybacks while BB is 78.72%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.